Skip to main content

Table 2 Antifungal treatment strategies

From: Analysis of cerebrospinal fluid protein concentrations of patients with cryptococcal meningitis treated with antifungal agents

Antifungal strategies

PR-group (n = 28)

GR-group (n = 18)

P-value

AMB

1(3.57 %)

1(5.56 %)

1.00

AMB+ flucytosine

5(17.9 %)

5(27.8 %)

0.73

AMB+ fluconazole

5(17.9 %)

2(11.1 %)

0.70

AMB+ fluconazole + flucytosine

13(46.2 %)

7(38.9 %)

0.79

AMB+ voriconazole

0(0.00 %)

1(5.56 %)

0.44

Fluconazole

3(10.7 %)

0(0.00 %)

0.29

Fluconazole + flucytosine

0(0.00 %)

2(11.1 %)

0.17

Voriconazole

1(3.57 %)

0(0.00 %)

0.62